Bloom Energy, AbbVie, and Veeva Systems are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies focused on applying biological science and technology—such as genetic engineering, molecular biology, and cell therapy—to develop medical treatments, diagnostics, and other life-science products. Because these firms often invest heavily in research and clinical trials before generating product revenues, their stock prices can be highly volatile and sensitive to regulatory approvals and scientific breakthroughs. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.
Bloom Energy (BE)
Bloom Energy Corporation designs, manufactures, sells, and installs solid-oxide fuel cell systems for on-site power generation in the United States and internationally. The company offers Bloom Energy Server, a solid oxide technology that converts fuel, such as natural gas, biogas, hydrogen, or a blend of these fuels into electricity through an electrochemical process without combustion.
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Read Our Latest Research Report on ABBV
Veeva Systems (VEEV)
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read Our Latest Research Report on VEEV
Read More
- MarketBeat’s Top Five Stocks to Own in August 2025
- Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain
- Keurig Dr. Pepper Shares Plummet on Acquisition—Buy the Dip?
- Defense Dividends: 3 Strong Performers That Are Raising Payouts
- Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype?
- Snowflake’s Snowballing Business and Robust Stock Price Outlook